Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (321-330 of 417) with videos related to

Pageof 42
Sort By:
Journal of Hypertension|July 17, 2004
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR StudyMichel Marre, Juan Garcia Puig, Franciszek Kokot, et al.
American Journal of Hypertension|January 3, 2007
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetesJuan Garcia Puig, Michel Marre, Franciszek Kokot, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Journal of Hypertension|August 19, 2022
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of HypertensionGeorge Stergiou, Mattias Brunström, Thomas MacDonald, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Atherosclerosis. Supplements|February 16, 2021
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 studyJacek J Jóźwiak, Krzysztof Studziński, Tomasz Tomasik, et al.
Nature Reviews. Cardiology|July 21, 2025
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practiceLucas Lauder, Thomas Weber, Michael Böhm, et al.
Archives of Medical Science : AMS|September 21, 2023
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studiesPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.
Rheumatology International|November 10, 2021
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional studyPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.
Journal of the American College of Cardiology|November 10, 2022
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure RangeFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Pageof 42

Showing results (321-330 of 417) with videos related to

Sort By:
Pageof 42
Journal of Hypertension|July 17, 2004
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR StudyMichel Marre, Juan Garcia Puig, Franciszek Kokot, et al.
American Journal of Hypertension|January 3, 2007
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetesJuan Garcia Puig, Michel Marre, Franciszek Kokot, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Journal of Hypertension|August 19, 2022
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of HypertensionGeorge Stergiou, Mattias Brunström, Thomas MacDonald, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Atherosclerosis. Supplements|February 16, 2021
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 studyJacek J Jóźwiak, Krzysztof Studziński, Tomasz Tomasik, et al.
Nature Reviews. Cardiology|July 21, 2025
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practiceLucas Lauder, Thomas Weber, Michael Böhm, et al.
Archives of Medical Science : AMS|September 21, 2023
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studiesPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.
Rheumatology International|November 10, 2021
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional studyPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.
Journal of the American College of Cardiology|November 10, 2022
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure RangeFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Pageof 42